K, G., B, D., E, B., N, A., GR, B., S, C., . . . R, H. (2026). Impact of the 2023/24 Influenza Vaccination on Patients with Inflammatory Rheumatic Disease in Germany: Insights from a Nationwide, Longitudinal, Self-Reported Study. Vaccines, 14(2), . https://doi.org/10.3390/vaccines14020136
Chicago Style (17th ed.) CitationK, Gente, et al. "Impact of the 2023/24 Influenza Vaccination on Patients with Inflammatory Rheumatic Disease in Germany: Insights from a Nationwide, Longitudinal, Self-Reported Study." Vaccines 14, no. 2 (2026). https://doi.org/10.3390/vaccines14020136.
MLA (9th ed.) CitationK, Gente, et al. "Impact of the 2023/24 Influenza Vaccination on Patients with Inflammatory Rheumatic Disease in Germany: Insights from a Nationwide, Longitudinal, Self-Reported Study." Vaccines, vol. 14, no. 2, 2026, https://doi.org/10.3390/vaccines14020136.